Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How much more MOJO rising does this have?
Then they had better get the FDA approval fast! Thanks, I will live in a hut on the beach with a group of native ladies. That's the plan :))))))
Then they had better get the FDA approval fast! Thanks, I will live in a hut on the beach with a group of native ladies. That's the plan :))))))
UP 460% and a halt. OMG this is another episode of the Twilight Zone :)
That I have no clue but great question. We can look it up in their 10k filings
That I have no clue but great question. We can look it up in their 10k filings
Dude if this gets approved by the FDA then I will retire to Tahiti without a care in the world!
AI software expected to further enable Petros's efforts to make STENDRA the first ED product to be offered over the counter
HALTED @ 12.72
TIAN RUIXIANG Holdings Ltd’s Subsidiary Enters into Sale and Purchase Agreement for Licensed Insurance Broker in Hong Kong
BEIJING, Feb. 14, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that TRX HongKong Investment Limited (“TRX HongKong”), a wholly-owned subsidiary of the Company, has entered into a sale and purchase agreement (the “SPA”) to acquire Peak Consulting Services Limited (the “Target") from Yuefu Company Limited (the “Vendor”), the sole shareholder of the Target. The Target is a licensed insurance brokerage in Hong Kong. This strategic acquisition represents a milestone in the Company's business to expand into the Hong Kong insurance brokerage market.
Pursuant to the SPA, the proposed acquisition (the “Acquisition”) is conditioned upon, among other things, the completion of a satisfactory diligence review of the Target by TRX HongKong prior to the consummation of the Acquisition.
The total consideration for the Acquisition is $1.5 million, to be paid in 3,472,222 of the Company’s Class A ordinary shares, which was calculated based on $0.432 per share, equivalent to 80% of the closing price of $0.54 per share on January 31, 2024, on NASDAQ.
Upon the consummation of the Acquisition, the management of TRX HongKong will work closely with the management of the Target to aim for a seamless integration of operations in an effort to deliver enhanced value propositions to insurance clients in the Hong Kong market.
Mr. Zhe Wang, Chairman and CEO of TIAN RUIXIANG Holdings Ltd, stated, "This acquisition aligns with our long-term strategic vision of establishing a presence beyond mainland China’s insurance brokerage market. We are excited about the growth opportunities in the Hong Kong market and are committed to leveraging our expertise and resources in order to capitalize on such opportunities."
About TIAN RUIXIANG Holdings Ltd
TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker operating in China through its China-based variable interest entity. It distributes a wide range of insurance products, which are categorized into two major groups: (1) property and casualty insurance, such as automobile insurance, commercial property insurance, liability insurance; and (2) other insurance, such as life insurance and health insurance. For more information, visit the company's website at http://ir.tianrx.com/.
Forward-Looking Statements
And it helps me too. Loading my pockets with tons of cabbage! :)
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
94% of the Claims Were Found to be Novel
RA'ANANA, Israel, Feb. 14, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), is a breakthrough medical technology company targeting to supersede mechanical ventilators, has received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the revolutionary INSPIRA™ ART500 device. This innovation has 16 claims found to be novel.
https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
The orbiting blood oxygenation delivery system (VORTX™) is designed to oxygenate blood without fiber membranes, and we believe it is expected to revolutionize the medical landscape. The current fiber technologies used for blood oxygenation cause substantial damage to the patient's blood cells. Unlike the natural laminar blood flow in blood vessels inside the body, in existing fiber oxygenators, the blood is "forced" to flow in a harmful turbulent flow through many layers of fibers while experiencing friction and shear forces within the fiber walls. Since the fiber fabric is a significant resistor to blood flow, high-pressure differences are formed and cause significant damage to the various blood components, including, high hemolysis (breakdown of red cells), damage to white blood cells, activation of the inflammatory system in the body, activation of the immune system, and blood clotting.
We believe that the orbiting blood oxygenation delivery system is another potentially game-changing core technology of the INSPIRA ART500 device, in targeting the $19 billion mechanical ventilation market.
The INSPIRA ART500 is a breakthrough device, designed to empower breathing in patients that are awake, by continuously measuring the patient's blood parameters in real-time, and delivering needed oxygen volume straight into the blood. As the INSPIRA ART500 is to be equipped with the HYLA blood sensor, it is being designed to continuously scan the patient's blood, potentially allowing for real-time detection of changes in patient condition and providing physicians with decision-supportive data.
CEO of Inspira Technologies Dagi Ben-Noon: "We believe that this is a monumental advancement in the landscape of blood oxygenation technologies and a pivotal milestone and another key indicator of the INSPIRA ART500's core technological portfolio."
Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity. For more information, please visit our corporate website: https://inspira-technologies.com.
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses intended benefits and uses of its technology, that its technology has the potential to revolutionize the medical landscape, the target market for its product, the potential of its products to allow for real-time detection and the belief that the patent approval is a monumental advancement in the landscape of blood oxygenation technologies. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, www.sec.gov.
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
94% of the Claims Were Found to be Novel
RA'ANANA, Israel, Feb. 14, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), is a breakthrough medical technology company targeting to supersede mechanical ventilators, has received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the revolutionary INSPIRA™ ART500 device. This innovation has 16 claims found to be novel.
https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg
The orbiting blood oxygenation delivery system (VORTX™) is designed to oxygenate blood without fiber membranes, and we believe it is expected to revolutionize the medical landscape. The current fiber technologies used for blood oxygenation cause substantial damage to the patient's blood cells. Unlike the natural laminar blood flow in blood vessels inside the body, in existing fiber oxygenators, the blood is "forced" to flow in a harmful turbulent flow through many layers of fibers while experiencing friction and shear forces within the fiber walls. Since the fiber fabric is a significant resistor to blood flow, high-pressure differences are formed and cause significant damage to the various blood components, including, high hemolysis (breakdown of red cells), damage to white blood cells, activation of the inflammatory system in the body, activation of the immune system, and blood clotting.
We believe that the orbiting blood oxygenation delivery system is another potentially game-changing core technology of the INSPIRA ART500 device, in targeting the $19 billion mechanical ventilation market.
The INSPIRA ART500 is a breakthrough device, designed to empower breathing in patients that are awake, by continuously measuring the patient's blood parameters in real-time, and delivering needed oxygen volume straight into the blood. As the INSPIRA ART500 is to be equipped with the HYLA blood sensor, it is being designed to continuously scan the patient's blood, potentially allowing for real-time detection of changes in patient condition and providing physicians with decision-supportive data.
CEO of Inspira Technologies Dagi Ben-Noon: "We believe that this is a monumental advancement in the landscape of blood oxygenation technologies and a pivotal milestone and another key indicator of the INSPIRA ART500's core technological portfolio."
Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity. For more information, please visit our corporate website: https://inspira-technologies.com.
Forward-Looking Statement Disclaimer
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses intended benefits and uses of its technology, that its technology has the potential to revolutionize the medical landscape, the target market for its product, the potential of its products to allow for real-time detection and the belief that the patent approval is a monumental advancement in the landscape of blood oxygenation technologies. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, www.sec.gov.
BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
Download as PDFFebruary 14, 2024 7:45am EST
Company announces preliminary fourth-quarter 2023 revenue record in excess of $42 million, as well as a record-breaking full-year 2023 revenue in excess of $140 million. Blink reaffirms its target for achieving positive Adjusted EBITDA run rate by December 2024
Miami Beach, FL., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK) (“Blink” or the “Company”), a leading manufacturer, owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that it anticipates its fourth-quarter 2023 revenue to surpass $42 million. With this achievement, the Company expects full-year 2023 revenue to surpass $140 million, exceeding its previously announced revenue target of $128 - $133 million.
Brendan Jones, President and CEO, said: “We are excited about our record-breaking fourth-quarter and full-year 2023 revenue growth. We saw strong demand for both our equipment and services. This is the result of consistent and systematic steps that we took to strengthen our product portfolio and service offerings, supported by our vertical integration strategy and dedicated customer service team”.
Blink also reaffirms its target of achieving a positive Adjusted EBITDA run rate by December 2024.
“By adopting the ‘right charger, right place, right time’ approach, Blink ensures electric vehicle charging is efficient and readily available, encouraging more people to make the switch to sustainable transportation,” stated Brendan Jones, considering preliminary year-end financial results. The success of Blink’s demonstrated progress reflects on the proven track record in strategically deploying nationwide EV charging infrastructure and ensuring widespread charger availability.
Blink will announce its fourth-quarter 2023 earnings call date, dial-in details, and further information at a later date.
###
Welcome to a different universe of the stock market where things out of the Twilight Zone come to realization :)
On fire because it is the year of the Dragon. Fire breathing Dragen that is :))))
On fire because it is the year of the Dragon. Fire breathing Dragen that is :))))
CNEY Will Host a Conference Call on February 16, 2024
LISHUI, China, Feb. 12, 2024 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) (the "Company" or "CNEY") today announced the Company will host a conference call to discuss the second half-year and full-year 2023 financial results on February 16, 2024, at 5:30 PM ET. The Company's second half-year and full-year 2023 financial results are expected to be announced on February 15, 2024.
Webcast:
A live webcast of the conference call will be available via the investor conference call section of https://cneny.com/ or by accessing the webcast link directly at https://cneny.com/events/.
About CN Energy Group. Inc.
CN Energy Group. Inc. is currently listed on NASDAQ under the symbol of CNEY. With patented proprietary bioengineering and physiochemical technologies, CNEY has pioneered and specialized in producing high-quality recyclable activated carbon and renewable energy from abandoned forest and agricultural residues, converting harmful wastes into invaluable wealth and delivering significant financial, economic, environmental, and ecologic benefits. CENY's products and services have been widely used by food and beverage producers, industrial and pharmaceutical manufacturers, as well as environmental protection enterprises. For more information, please visit the Company's website at www.cneny.com.
Yes sir! Great tip bro! riding this baby to a new universe! :) Thank you
Yes sir! Great tip bro! riding this baby to a new universe! :) Thank you
Datasea Reports Second Quarter Fiscal Year 2024 Financial Results and Operations Update - Second Quarter Revenue is $11.3 Million Versus $0.1 Million in the Year-Ago Period
BEIJING, Feb. 13, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G multimodal communication, upgraded 5G messaging services, today announced its financial results for the second quarter ended December 31, 2023.
"We delivered strong performance in our second quarter of 2024 with revenue of approximately $11.3 million which brought our first half revenue of 2024 to $18.2 million. The increase in revenue during the quarter was mainly due to an increase of our 5G multimodal communication business in China where we signed a number of significant 5G multimodal communication service agreements. Our sales team vigorously and effectively promote our products where we focus on the needs of our customers and constantly optimize and improve our products and services. We believe that our technology has competitive advantages in its accuracy, convenience and technological capabilities," said Datasea CEO Zhixin Liu.
"We launched our air sterilization products in China in 2023 across a number of distribution channels and we are currently developing our business operations in the US which include our pursuit of intellectual property rights and the establishment of an online platform. In the post-pandemic era, we believe that there is a global demand for effective solutions for healthy living environments in China, the US and globally. We are committed to providing cutting-edge acoustics technology imbedded with artificial intelligence across a wide range of products for both business and consumer applications," concluded CEO Zhixin Liu of Datasea.
First Half Fiscal Year 2024 Financial Highlights
For the six months ended December 31, 2023 and 2022, revenues were $18,229,212 and $131,459, respectively. Revenues increased by $18,097,753 over the same period of last year, an increase of 13,766.8% over the same period of last year, mainly due the Company's is current leadership in the research and development of 5G multimodal communication technology, where it has formed a stable customer base after a sustained expansion of its customer base. In addition to Datasea's technological R&D achievements over the years, our improved market positioning is due to extensive market promotion and our exceptional customer support. In addition, the structural dynamics in which we operate have improved with the general development of the 5G upstream and downstream chain, which has led to a thriving 5G market and the formation of a very sizeable and loyal customer base.
For the six months ended December 31, 2023 and 2022, the Company's administrative expenses were $1,316,516 and $1,751,359, respectively, a decrease of $434,843 or 24.8%, compared to the same period last year. The main reason is that the Company continues to rationalize its administrative expenses, improve its operational efficiency, and improve the granularity of its expenses to improve management efficiency and reduce expenses.
As of December 31, 2023 and June 30, 2023, the Company's accounts receivable balance were $54,123 and $255,725, respectively, a decrease of $201,602 and 78.8% from the prior period. Mainly, the Company reduced the occurrence of bad debts by strengthening the credit evaluation of customers, strengthened its collection processes including collection efficiency and shortened the account period, all of which improved the management efficiency of its accounts receivable.
Operations Update
Acoustic Intelligence
Datasea is a developer and promoter of acoustic intelligence and plans to introduce Its cutting-edge technology and its wide range of applications to China, US and globally. The Company's intelligent acoustics products segment is central to its strategic growth plan. Its acoustic effects are derived by reverse engineering sound characteristics and developing processing mechanisms from the perspective of how sound impacts people and objects. This has led the Company to develop acoustic products that address real-world problems across a range of industries. In 2023, Datasea launched air sterilizer products in China and has been promoting its products through direct sales, channel agents and livestreaming. The Company is currently establishing the protocols for the marketing and sales of such products in the US.
International Business Expansion: Datasea established its wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, USA in July 2023. This was a key element in its strategic plan and underlies Datasea's commitment to intelligent acoustics and its intent to offer leading-edge acoustic solutions to the U.S. market. Datasea has developed high-quality ultrasonic air sterilizers, bathroom and cloakroom sterilizers, and odor removal products. Further, it has engaged in the continuous development of new products including ultrasonic Skin Repair Robots and Schumann frequency sleep monitors for the China, US and global markets. The Company has commenced a collaboration with a globally renowned testing organization, to conduct ETL safety and functional certifications for the air disinfection products intended for sale in the US. Datasea anticipates completing these certifications in the next quarter and commencing the sales of its products in the US market.
Marketing and sales expansion. Datasea plans to actively seek long-term contracts and collaborations with domestic and international customers, partners, and major corporate clients. On October, 2023, its Delaware operating entity, Datasea Acoustics LLC, entered into a marketing promotion and sales cooperation agreement with Meglio Interiors LLC ("Meglio"), based in Chamblee, Georgia to develop, promote and distribute the Company's intelligent acoustics products in the US and internationally. Meglio has sales channels that include Atlanta, Dallas and New Jersey and broad experience in increasing sales for its clients in the US. The Company believes that Meglio has the know-how in business development, marketing, sales, branding, and channel development in the US furniture market, which the Company believes is an ideal fit for its home health products which include air disinfection machines, bathroom and wardrobe deodorization devices as well as sleep-enhancing products.
Technology Collaborations: Datasea believes that it is at the forefront of delivering cutting-edge intelligent acoustics solutions, especially focusing on ultrasound, infrasound, directional sound and Schumann resonance technology, to meet the evolving needs of our customers worldwide. DTSS has entered into collaborations with renowned research institutions such as the Medical Ultrasound Project with the Chinese Academy of Sciences and the ultrasound-based products for mental alertness and attention enhancement. In addition, Datasea plans to foster collaborations with renowned U.S. universities and research institutions through its US subsidiary. By partnering with these institutions. The Company believes that this collaborative approach will help Datasea to develop and sustain a technological leadership position in the ultrasonic, infrasound and directional sound technology fields.
US Patent Acquisition and Technology Protection: Datasea prioritizes the acquisition of US patents to protect its innovations and intellectual property. Our attainment of US patents for our technologies is essential to maintain our competitive advantage and defend against potential infringement. We believe that our planned patent acquisition will ensure that Datasea's intellectual property remains protected in the US market and provide opportunities for licensing and monetization. Currently, the Company is actively engaged in obtaining U.S. patents through collaboration with a renowned intellectual property firm. We aim to build an intellectual property matrix in the United States and on an international scale.
5G Multimodal Communication
Marketing and sales expansion. Datasea is a first pioneer in the 5G multimodal communication, upgraded 5G messaging services in China, and has built a comprehensive 5G multimodal communication product portfolio with high brand recognition. With the rapid development of 5G multimodal communication in the Chinese market, its application trend will show the characteristics of intelligence, strong connectivity, immersive experience, enabling thousands of industries, personalized service and border blurring, and promote the digital transformation and intelligent development of all walks of life. The Company's communication suite enables users to enjoy various effective interfaces with integrated messages, including texts, pictures, audio, video and emojis, as well as status, location and other communication functions. It has the characteristics of high contact rate, rich media, strong interactivity, convenient service, and high security. Datasea has adopted an integrated sales strategy to boost sales to better promote business development and meet the demand of its customers.
Key Customers and Agreements. As of December 31, 2023, Datasea's Chinese operating entities have reached agreements with two important new clients, Hainuo Xintong (Qingdao) Network Technology Co., Ltd. ("Hainuo") and Xiamen Duoqiao Mai Network Technology Co., Ltd. ("Xiamen Duoqiao"). These agreements allow Hainuo and Xiamen Duoqiao to purchase various denominations of 5G message top up cards within 12 months of the agreement, ranging from RMB 10 to RMB 500 ($1.38 to $69.40). Just a few months after signing agreements with Hainuo and Xiamen Duoqiao, DTSS' subsidiaries recorded a 5G multimodal communication service contract worth approximately $10.49 million. In addition, as of December 31, 2023, one of Datasea's operating entities, Guozhong Times (Beijing( Technology Co., Ltd. has agreed to terms with several new clients for 5G multimodal communication business that will result in significant revenue.
About Datasea Inc.
Datasea Inc. ("Datasea") is a leading provider of products, services, and solutions for enterprise and retail customers in converging and innovative industries, Intelligent Acoustics and 5G multimodal communication especially focusing on ultrasonic, infrasound and directional sound technology. The Company's advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal communication segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies in intelligent acoustics, utilizing ultrasonic sterilization to combat viruses and prevent human infections, and is also developing innovations in directional sound and medical ultrasonic cosmetology. In July 2023, Datasea established a wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to mark its global presence. This underlies Datasea's commitment to Intelligent Acoustics and its intent to offer leading-edge acoustic solutions to the US market. For additional information, please visit: www.dataseainc.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook," "objective" and similar terms. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond Datasea's control, which may cause Datasea's actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to Datasea as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in Datasea's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. Datasea does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Datasea Investor and Media Contact:
Here you go again!
Thank you, bro! Although I am trained to do mathematics in DD and take my vision into the future of a company's stock, I have made most of my money during the past 3 years on pure luck mostly day trading stocks that are being pumped from who knows where. Luck
Nice bro! I'm in on that 30% dip. I have been lucky this month so will let her ride! :))
Closed up 74% so nice! Excited to see how she opens on pre-markets. :)
AH HA, and it is out of Japan. Do you like it on the dip? up 30%
And it's not even from China or the Far East. It's from Ireland lmao
Try and catch this one!!!!!! lol
Thinking about reentering
Thanks gail. Been up since 4amEST looking for the BS. Take good care!
Even 1 favorable FDA answer and PTPI is a moon shot! Buy and hold until then
up 671% and I ran out of smelling salts!
I'm out at $6:75 gail. I was contemplating getting back in under $2.80 but there are so many other POS P&Ds to buy. :)
HALTED @ 535% ***&((^
Hey VinnyVega, it's a pure P&D, and maybe a round 2 pump on the way? :)
Been halted so many times that I stopped counting. I'm sure the float is tiny
There was a massive buying spree during the pre-market of 1.2 million shares! Remember there are not 1 but 2 FDA meetings in March! :)
I'm sure the Company will tell you it was a delayed reaction from their 2/8/24 news.
Ohmyhome Announces Growth Updates Following Successful Acquisition of Property Management Business Simply Sakal
Units under management reached 6,746 units, with an Annual Recurring Revenue (ARR) of over $2.7 million (SGD 3.6 million), and additional SaaS revenue streams.
Singapore, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore, is pleased to announce significant developments and milestones following its acquisition of Simply Sakal Pte. Ltd.
Simply Sakal Pte. Ltd. is now renamed as Ohmyhome Property Management further enhancing the one-stop brand of Ohmyhome.
This strategic transaction has not only expanded Ohmyhome's service offerings to include a non-cyclical recurring revenue stream, but also established a strong position in the condominium property management sector in Singapore with close to 6,800 units under management and an ARR reaching $2.7 million (SGD 3.6 million) on December 31, 2023. The condominiums are across various districts in Singapore with sizes ranging from 10 to over 700 units per project.
The property management business has historically grown its business at 57% CAGR (Compound Annual Growth Rate), achieving revenue of $2.0 million (SGD 2.6 million) in 2022 with 4,648 units under management.
Integration and Potential Synergies
Ohmyhome’s suite of services are now fully integrated and accessible in the Simple App, the property management mobile application used by the homeowners and residents of the units managed by Ohmyhome Property Management. In addition to the property management revenue stream to Ohmyhome as a combined entity, there are also significant potential synergies arising from the customers residing in the condominium units.
https://ml.globenewswire.com/Resource/Download/c06651b3-8f23-447e-ba06-7d053b1d8d61/image2.png
Simple App with Ohmyhome’s Services Integrated
Historically, Ohmyhome has primarily been active in the Housing Development Board (HDB) resale market where home values are around $0.3 to 0.8 million, with average revenue per transaction at around $4,000 at 1% commission. The integration allows Ohmyhome to quickly enter into the private condominium market where home values in Singapore typically range from $1 to 2.5 million and a revenue per transaction that would be 2 to 5 times higher ranging from $10,000 to $25,000. This would result in a lower cost of customer acquisition as compared to other agents as Ohmyhome is now seen in the daily life of the residents of the enclosed condominium communities. Renovation contracts for private condominium renovation ($40,000 - 80,000) are also typically higher than HDB flats ($20,000 - 50,000).
https://ml.globenewswire.com/Resource/Download/efd53389-727e-4d61-882d-d31c83c6a051/image3.png
Kenneth Chong, CEO of Ohmyhome Property Management (Left) with Race Wong and Rhonda Wong, Co-founders of Ohmyhome (Right)
Following the acquisition, Ohmyhome Property Management has relocated its office to merge with Ohmyhome's headquarters at 11 Lor 3 Toa Payoh, Jackson Square Block B #04-17, Proptech Innovation Centre, Singapore 319579. This creates cost synergies through the consolidation of office spaces as well as back-office functions, which streamlines operations and enhances efficiency across both companies.
New Revenue Streams and IoT Integrations
To redefine property management, Ohmyhome Property Management has also introduced Vehicle Management Systems for condominiums as a new Software-as-a-Service (SaaS) revenue source in Q4 2023 through the integration of Internet of Things (IoT) solutions. We believe this new service, focusing on resident and visitor vehicle management on a subscription model, represents a leap forward in enhancing property security and efficiency.
https://ml.globenewswire.com/Resource/Download/00ff815d-9eac-4fa5-8a09-11389b62eb66/image4.png
Illustration of Ohmyhome Property Management’s Vehicle Management System
The IoT solutions streamline vehicle entry and exit processes, allowing for pre-registered vehicles to enter and exit the estates freely without the need for human security details. We believe this offers a modern, secure, and seamless experience for both residents and property managers, and leads to savings for the Management Corporation Strata Titles (MCSTs), and further solidifies Ohmyhome Property Management as an industry leader in bringing technology to property management, where the industry is mostly paper-based and manpower intensive. As a technology player in the property management industry, Ohmyhome Property Management has the capability to integrate additional IoT solutions and services beyond its current functionalities to provide more convenience to the residents.
A Property SuperApp and Expected Growth Ahead
This post-acquisition phase marks the beginning of a new era for Ohmyhome, further propelling the growth of the combined company to become a property SuperApp. With a combined portfolio of services and customers, we believe the Company is set to deliver value and service to its clients, and additional growth curves from the ever expanding customer base of homeowners and home seekers.
Rhonda Wong, CEO and Co-founder of Ohmyhome, stated “We are extremely excited about the opportunities ahead of us with the successful integration of our new property management arm headed by a talented and dedicated team of seasoned professionals.”
About Ohmyhome
Ohmyhome is a one-stop-shop property technology platform in Singapore that provides end-to-end property solutions and services to buy, sell, rent, and renovate homes, as well as property management services for condominiums in Singapore. Since its launch in 2016, Ohmyhome has transacted over 14,500 properties, and has over 5,800 units under management as of June 30, 2023. It is also the highest-rated property transaction platform, with more than 8,000 genuine reviews, and an average rating of 4.9 out of 5 stars.
Ohmyhome is dedicated to bringing speed, ease, and reliability to property-related services and to becoming the most trusted and comprehensive property solution for everyone.
For more information, visit: https://ohmyhome.com/en-sg/
Safe Harbor Statement
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.
Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made fr
HALTED @ $1.82
Is this you buying up this low float?